Startseite The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6
Artikel Open Access

The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6

  • Pingqiao Wang , Yunlong Zhu , Haixin Ding ORCID logo und Haiyang Huang ORCID logo EMAIL logo
Veröffentlicht/Copyright: 16. Mai 2023
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 238 Heft 4

Abstract

C49H52Cl2N10O6, monoclinic, P21 (no. 4), a = 12.2875(14) Å, b = 8.3031(10) Å, c = 13.1242(15) Å, β =  100.0640 ( 10 ) ∘ , V = 1318.4(3) Å3, Z = 1, R g t (F) = 0.0736, w R r e f (F 2) = 0.1545, T = 296 K.

CCDC no.: 2248075

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.28 × 0.26 × 0.20 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.18 mm−1
Diffractometer, scan mode: φ and ω
θ max, completeness: 27.7°, 99%
N(hkl)measured, N(hkl)unique, R int: 10,614, 5454, 0.016
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 4318
N(param)refined: 344
Programs: Bruker [1], SHELX [2, 3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
O1 0.6809 (4) 1.0687 (5) 0.9217 (3) 0.0711 (13)
O2 0.7512 (4) 0.7216 (5) 1.0509 (3) 0.0749 (13)
O3 0.8512 (4) 0.9645 (7) 0.8134 (3) 0.0857 (15)
N1 0.5765 (4) 0.7728 (5) 0.8016 (3) 0.0453 (10)
N2 0.5600 (4) 0.8424 (5) 0.6239 (3) 0.0495 (11)
N3 0.4907 (4) 0.4149 (5) 0.6637 (3) 0.0549 (12)
N4 0.5318 (4) 0.4931 (6) 0.8342 (3) 0.0560 (12)
N5 0.5039 (5) 0.6628 (5) 0.4913 (3) 0.0592 (13)
H5A 0.5087 0.7397 0.4485 0.071*
H5B 0.4835 0.5684 0.4687 0.071*
C1 0.5831 (6) 0.9853 (7) 0.9355 (4) 0.0638 (16)
H1A 0.5194 1.0259 0.8883 0.077*
H1B 0.5700 0.9972 1.0059 0.077*
C2 0.6048 (5) 0.8112 (6) 0.9122 (4) 0.0486 (13)
H2 0.5635 0.7408 0.9516 0.058*
C3 0.7303 (5) 0.7942 (7) 0.9535 (4) 0.0591 (15)
H3 0.7670 0.7358 0.9041 0.071*
C4 0.7709 (6) 0.9690 (8) 0.9659 (4) 0.0691 (18)
H4 0.7889 0.9930 1.0400 0.083*
C5 0.5830 (5) 0.8755 (7) 0.7241 (4) 0.0515 (13)
H5 0.6058 0.9799 0.7423 0.062*
C6 0.5279 (4) 0.6897 (6) 0.5924 (3) 0.0432 (11)
C7 0.5210 (5) 0.5737 (6) 0.6687 (4) 0.0437 (12)
C8 0.5453 (4) 0.6159 (6) 0.7724 (4) 0.0430 (12)
C9 0.4993 (6) 0.3761 (7) 0.7631 (4) 0.0624 (17)
H9 0.4835 0.2725 0.7832 0.075*
C10 0.7479 (7) 0.5497(8) 1.0464 (5) 0.078 (2)
H10A 0.8154 0.5099 1.0267 0.094*
H10B 0.6864 0.5159 0.9940 0.094*
C11 0.7353 (5) 0.4788 (8) 1.1488 (4) 0.0621 (15)
C12 0.7300 (7) 0.3123 (8) 1.1589 (6) 0.080 (2)
H12 0.7342 0.2473 1.1020 0.096*
C13 0.7186 (7) 0.2424 (11) 1.2509 (7) 0.094 (2)
H13 0.7165 0.1308 1.2566 0.112*
C14 0.7102 (6) 0.3392 (11) 1.3363 (6) 0.089 (2)
H14 0.7023 0.2931 1.3992 0.107*
C15 0.7137 (7) 0.5019 (12) 1.3259 (6) 0.089 (2)
H15 0.7061 0.5674 1.3817 0.107*
C16 0.7282 (6) 0.5710 (9) 1.2344 (5) 0.0729 (19)
H16 0.7334 0.6824 1.2302 0.088*
C17 0.8686 (7) 1.0129 (11) 0.9179 (5) 0.094 (3)
H17A 0.8802 1.1285 0.9223 0.113*
H17B 0.9343 0.9607 0.9552 0.113*
C18 0.9365 (7) 1.0161 (12) 0.7630 (6) 0.103 (3)
H18A 1.0063 0.9716 0.7974 0.124*
H18B 0.9419 1.1326 0.7660 0.124*
C19 0.9136 (6) 0.9617 (10) 0.6510 (6) 0.082 (2)
C20 0.8159 (7) 0.9856 (11) 0.5894 (7) 0.091 (2)
H20 0.7604 1.0406 0.6147 0.109*
C21 0.7963 (7) 0.9279 (13) 0.4859 (7) 0.103 (3)
H21 0.7274 0.9398 0.4440 0.123*
C22 0.8845 (11) 0.8519 (15) 0.4485 (8) 0.131 (4)
H22 0.8742 0.8156 0.3804 0.158*
C23 0.9865 (10) 0.8309 (14) 0.5123 (10) 0.126 (4)
H23 1.0455 0.7829 0.4882 0.152*
C24 0.9962 (7) 0.8847 (14) 0.6133 (8) 0.117 (3)
H24 1.0628 0.8673 0.6580 0.141*
C25a 0.8801 (13) 0.5516 (19) 0.7106 (13) 0.118 (11)
H25Aa 0.8501 0.6581 0.7185 0.141*
H25Ba 0.9055 0.5495 0.6446 0.141*
Cl1a 0.9913 (10) 0.5234 (13) 0.8067 (7) 0.137 (4)
Cl2a 0.7787 (6) 0.4180 (14) 0.7065 (16) 0.178 (8)
C25b’ 0.807 (2) 0.437 (5) 0.7672 (14) 0.035 (9)
H25Cb 0.8028 0.3329 0.8004 0.042*
H25Db 0.7521 0.5071 0.7887 0.042*
Cl1′b 0.9374 (13) 0.5180 (19) 0.8048 (14) 0.081 (6)
Cl2′b 0.780 (2) 0.414 (3) 0.6367 (11) 0.094 (7)

  1. aOccupancy: 0.362(10), boccupancy: 0.138(10).

1 Source of materials

An improved synthesis was performed which was similar to the previous report [5]. To the solution of 3, 5-O-dibenzyl-2-methylsulfonyl-1-deoxy-d-ribose (5.00 g, 12.7 mmol) in anhydrous dimethylformamide (100 mL) was added adenine (3.44 g, 25.5 mmol), K2CO3 (3.52 g, 25.5 mmol) and 18-crown 6-ether (13.47 g, 51.0 mmol) under an argon atmosphere. After addition, the reaction mixture was heated at 110 °C for 10 h. TLC detection showed the reaction was finished. After filtration, the solvent was removed in vacuo. The obtained residue was dissolved in dichloromethane (100 mL), washed with water (50 mL × 2), brine (50 mL × 2), and dried over anhydrous MgSO4. After filtration, the solvent was evaporated in vacuo. The obtained residue was purified by column chromatography to afford white solid of N 9-isoadenosine (4.67 g, 85%) and the title compound N 3-isoadenosine (0.39 g, 7%), which was further purified by recrystallization from dichloromethane and methanol. Crystals were obtained by slow evaporation from the solution at 268–270 K.

2 Experimental details

Restrained distances: C25–Cl1 = C25–Cl2 = C25′–Cl1′ = C25′–Cl2′; U iso/U aniso restraints and constraints: U anis(C25′)1.2U eq: with sigma of 0.01 and sigma for terminal atoms of 0.02; Secondary CH2 refined with riding coordinates: C1(H1A, H1B), C10(H10A, H10B), C17(H17A, H17B), C18(H18A, H18B), C25(H25A, H25B), C25′ (H25C, H25D); Aromatic/amide H refined with riding coordinates: C5(H5), C9(H9), C12(H12),

3 Comment

Isonucleoside (iso-NA) is a nucleoside isomer, in which the nucleobase is moved from C-1 to other positions of ribose, that showed effective activity against a broad spectrum of viruses and good resistance to enzyme hydrolysis [6], [7], [8]. Moreover, Antisense oligonucleotides (ASONs) and siRNA modified with isonucleoside showed promising therapeutic potential and gene silencing activities [9–10]. It is significant to construct new isonucleoside derivatives for drug candidate [11], [12], [13]. In this paper, 1′-deoxy-2′-d-isonucleosides were synthesized by combining 3,5-O-dibenzyl-2-methylsulfonyl-1-deoxy-d-ribose with adenine by nucleophilic substitution. After the reaction, three isomers, N 9, N 7 and N 3, were obtained with yield of N 9 (85%), N 7 (3%) and N 3 (7%), respectively. In the literature, detailed analysis of all three isomers was not reported before and their NMR spectrum are very similar. Fortunately, the crystal structures of N 3-isoadenosine (3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine) was obtained by continuous adjustment of crystallization conditions. It is very helpful for determination of the exact structures of all three isomers. In the meantime, it is very significant for further understanding their interaction with reverse transcriptase. The title structure (see the Figure) contains one isoadenosine and one irregular dichloromethane solvent molecule. The isoadenosine consists of a benzyl-protected 1-deoxyribose and an adenine fragment by a C2–N1 bonding at 1.467(6) Å, where the glycosidic bond is an axial direction on the C2-position of furanose ring with torsion angle of 31 . 26 o (C1–C2–N1–C5) and is in a same orientation to C4–C17 bond (that is, in beta-configuration). The bond lengths and angles are in the expected ranges.

Corresponding author: Haiyang Huang, Jiangxi Key Laboratory of Organic Chemistry, Jiangxi Science & Technology Normal University, Nanchang 330013, People’s Republic of China, E-mail:

Acknowledgements

This work was supported by the Jiangxi Provincial Natural Science Foundation (20224BAB203006), the Education Department of Jiangxi Province (No. GJJ2201315), and the Open Foundation (No. 2022KFJJ003) of Jiangxi Science & Technology Normal University.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: Jiangxi Provincial Natural Science Foundation (20224BAB203006), the Education Department of Jiangxi Province (No. GJJ2201315), and the Open Foundation (No. 2022KFJJ003) of Jiangxi Science & Technology Normal University.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article

References

1. BRUKER. Saint, Apex2 and Sadabs; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8.10.1107/S2053273314026370Suche in Google Scholar PubMed PubMed Central

3. Sheldrick, G. M. Crystal structure refinement with Shelxl. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Suche in Google Scholar

5. Tino, J. A., Clark, J. M., Field, A. K., Jacobs, G. A., Lis, K. A., Michalik, T. L., McGeever-Rubin, B., Slusarchyk, W. A., Spergel, S. H. Synthesis and antiviral activity of novel isonucleoside analogs. J. Med. Chem. 1993, 36, 1221–1229; https://doi.org/10.1021/jm00061a013.Suche in Google Scholar PubMed

6. Onitsuka, K., Yamaguchi, K., Tokuda, R., Higashi-Kuwata, N., Kuwahara, S., Kumamoto, H., Maeda, K., Haraguchi, K., Mitsuya, H., Imoto, S. Design and synthesis of 4′-cyano dideoxy isonucleosides and their activity against HIV-1 and HBV. Heterocycles 2020, 100, 1599–1612; https://doi.org/10.3987/com-20-14312.Suche in Google Scholar

7. Nair, V. Antiviral isonucleosides: discovery, chemistry and chemical biology. In Recent Advances in Nucleosides: Chemistry and Chemotherapy; Chu, C. K., Ed.; Elsevier: Oxford, 2002; pp. 149–166.10.1016/B978-044450951-2/50006-0Suche in Google Scholar

8. Fan, X., Sun, L., Li, K., Yang, X., Cai, B., Zhang, Y., Zhu, Y., Ma, Y., Guan, Z., Wu, Y., Zhang, L., Yang, Z. The bioactivity of d-/l-isonucleoside- and 2′-deoxyinosine-incorporated aptamer AS1411s including DNA replication/microRNA expression. Mol. Ther. Nucleic Acids 2017, 9, 218–229; https://doi.org/10.1016/j.omtn.2017.09.010.Suche in Google Scholar PubMed PubMed Central

9. Zhang, J., Chen, Y., Huang, Y., Jin, H.-W., Qiao, R.-P., Xing, L., Zhang, L.-R., Yang, Z.-J., Zhang, L.-H. Synthesis and properties of novel l-isonucleoside modified oligonucleotides and siRNAs. Org. Biomol. Chem. 2012, 10, 7566–7577; https://doi.org/10.1039/c2ob26219c.Suche in Google Scholar PubMed

10. Huang, Y., Chen, Z., Chen, Y., Zhang, H., Zhang, Y., Zhao, Y., Yang, Z.-J., Zhang, L.-H. Effects of conformational alteration induced by d-/l-isonucleoside incorporation in siRNA on their stability in serum and silencing activity. Bioconjugate Chem. 2013, 24, 951–959; https://doi.org/10.1021/bc300642u.Suche in Google Scholar PubMed

11. Tang, J., Dong, X.-Y., Ouyang, W.-L., Zhu, Y.-L., Ding, H.-X., Xiao, Q. Studies on total synthesis of iso-l-guanosine. Chin. J. Org. Chem. 2019, 39, 2609–2615; https://doi.org/10.6023/cjoc201901045.Suche in Google Scholar

12. Sun, Z.-D., Zhu, Y.-L., Huang, H.-Y., Song, X.-R., Xiao, Q. Studies on the total synthesis of iso-l-cystidine. Chin. J. Org. Chem. 2016, 36, 2729–2734; https://doi.org/10.6023/cjoc201605036.Suche in Google Scholar

13. Fortuna, A., Goncalves-Pereira, R., Costa, P. J., Jorda, R., Vojackova, V., Gonzalez, G., Heise, N. V., Csuk, R., Oliveira, M. C., Xavier, N. M. Synthesis and exploitation of the biological profile of novel guanidino xylofuranose derivatives. ChemMedChem 2022, 17, e202200180; https://doi.org/10.1002/cmdc.202200180.Suche in Google Scholar PubMed

Received: 2023-03-16
Accepted: 2023-05-01
Published Online: 2023-05-16
Published in Print: 2023-08-28

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of a polymorph of potassium picrate, C6H2KN3O7
  4. The crystal structure of (1E,2E)-1,2-bis(quinolin-2-ylmethylene)hydrazine, C20H14N4
  5. 5-Amino-2-chloro-4-fluoro-N-(N-isopropyl-N-methylsulfamoyl) benzamide, C11H15O3ClFN3S
  6. Crystal structure of trans-N 1,N 8-bis(2-cyanoethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H42N6
  7. The crystal structure of [N-{[2-(oxy)-4-methoxyphenyl](phenyl)methylidene}alaninato]-diphenyl-silicon(IV) – chloroform (1/1), C29H25NO4Si·CHCl3
  8. Crystal structure of tetracarbonyl-{μ-[N-(diphenylphosphanyl)-N,P,P-triphenylphosphinous amide]}-bis[μ-(phenylmethanethiolato)]diiron (Fe–Fe), C48H39Fe2NO4P2S2
  9. Crystal structure of baryte from Mine du Pradet (France)
  10. The crystal structure of [(2,2′-bipyridine-6-carboxylato-κ3 N,N,O)-(6-phenylpyridine-2-carboxylate-κ2 N,O)copper(II)] monohydrate, C23H17N3O5Cu
  11. Crystal structure of bis(μ-benzeneselenolato)-(μ-[N-benzyl-N-(diphenylphosphanyl)-P,P-diphenylphosphinous amide])-tetracarbonyl diiron (Fe–Fe), C47H37Fe2NO4P2Se2
  12. The crystal structure of diaqua-methanol-κ1 O- (3-thiophenecarboxylato-κO)-(2,2′-dipyridyl-κ2 N,N′)manganese(II) 3-thiophenecarboxylate, C21H22N2O7S2Mn
  13. Crystal structure of catena-poly[tetrakis(butyl)-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O:O,O′,N-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O,N,O′:N′-ditin(IV)], C34H50N6O6Sn2
  14. Crystal structure of 4-chloro-N′-[(1E)-(2-nitrophenyl)methylidene]benzohydrazide, C14H10ClN3O3
  15. The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6
  16. The crystal structure of (Z)-4-amino-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H17N3O
  17. The co-crystal structure of etoricoxib–phthalic acid (1/1), C18H15ClN2O2S·C8H6O4
  18. Crystal structure of (glycinto-κ 2 O,N ′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ 4 N,N ′,N ″,N ‴]nickel(II) perchlorate monohydrate C18H42ClN5NiO7
  19. The crystal structure of catena-poly[bis(1-ethylimidazole-k1 N)-(μ 2-benzene-1-carboxyl-3,5-dicarboxylato-κ 2 O, O′)zinc(II)], C19H20N4O6Zn
  20. Crystal structure of 3-(thiazol-2-ylcarbamoyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C11H12N2O4S
  21. Rietveld structure analysis of keatite, a rare, metastable SiO2 polymorph
  22. Crystal structure of catena-poly[(μ2-isophthalato-k3 O,O′:O″)(4-(4-pyridyl)-2,5-dipyrazylpyridine-k3 N,N′,N″)cobalt(II)] trihydrate C26H22N6O7Co1
  23. Crystal structure of 3,5–di-O-benzoyl-1,2-O-isopropylidene-α–D-ribose, C22H22O7
  24. The crystal structure of fac-tricarbonyl(6-bromo-2,2-bipyridine-κ2 N,N)-(nitrato-κO)rhenium(I), C13H7BrN3O6Re
  25. The crystal structure of (E)-N′-(4-hydroxy-3-methoxybenzylidene)-2-naphthohydrazide monohydrate, C19H18N2O4
  26. The crystal structure of 5,5′-diselanediyl-bis(2-hydroxybenzaldehyde), C14H10O4Se2
  27. The crystal structure of catena-poly[diaqua-m2-dicyanido-κ2 C:N-dicyanido-κ1 C-bis(4-(pyridin-4-yl)benzaldehyde-κ1N)iron(II)-platinum(II), C28H22N6O4PtFe
  28. Redetermination of the crystal structure of 5,14-dihydro-6,17-dimethyl-8,15-diphenyldibenzo(b,i)(1,4,8,11)tetra-azacyclotetradecine, C32H28N4
  29. Crystal structure of poly[(μ3-2-(3,5-dicarboxyphenyl) benzimidazole-6-carboxylato-κ4O:O:O′:O″)lead(II)] monohydrate, C16H10N2O7Pb
  30. The crystal structure of fac-tricarbonyl(2-pyridin-2-yl-quinoline-κ2 N,N′)-(pyrazole-κN)rhenium(I)nitrate, C20H14N4O3ReNO3
  31. Crystal structure of dibromo-dicarbonyl-bis(tricyclohexylphosphine)-osmium(II) dichloromethane solvate, C38H66Br2O2OsP2
  32. Crystal structure of poly[bis(μ 2-2,6-bis(1-imidazoly)pyridine-κ 2 N:N′)copper(II)] diperchlorate dihydrate, C22H22Cl2CuN10O10
  33. The crystal structure of fac-tricarbonyl(N-benzoyl-N,N-cyclohexylmethylcarbamimidothioato-κ2 S,O)-(pyridine-κN)rhenium(I), C23H24N3O4ReS
  34. Crystal structure of (E)-7-fluoro-2-(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O
  35. Synthesis and crystal structure of 1-((3R,10S,13S, 17S)-3-((2-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO2
  36. The crystal structure of fac-tricarbonyl((pyridin-2-yl)methanamino-κ2 N,N′)-((pyridin-2-yl)methanamino-κN)rhenium(I) nitrate, C15H16O3N4Re
  37. The crystal structure of (1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)-N-((1-(4-vinylbenzyl)-1H-benzo[d]imidazol-2-yl)methyl)methanamine-κ 4 N,N′,N″,N‴)tris(nitrato-kO,O′)-erbium(III), C29H27ErN8O9
  38. Crystal structure of tetracene-5,12-dione, C18H10O2
  39. Crystal structure of (3R,3aS,6R,6aR)-6-hexyl-3-methyltetrahydrofuro[3,4-b]furan-2,4-dione, C13H20O4
  40. The crystal structure of N′1,N′3-bis((E)-thiophen-2-ylmethylene)isophthalohydrazide monohydrate, C18H16N4O3S2
  41. Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S
  42. Crystal structure of (E)-3-(3-methoxybenzylidene)benzofuran-2(3H)-one, C16H12O3
  43. Synthesis and crystal structure (E)-1-(4-bromo-2-hydroxyphenyl)-3-(dimethylamino)prop-2-en-1-one, C11H12BrNO2
  44. Synthesis and crystal structure of (S,E)-4-hydroxy-3-(2-((4aR,6aS,7R,10aS,10bR)-3,3,6a,10b-tetramethyl-8-methylenedecahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)dihydrofuran-2(3H)-one, C23H34O5
  45. The crystal structure of N,N′-(1,2-phenylene)bis (2-((2-oxopropyl)selanyl)benzamide), C26H24N2O4Se2
  46. The crystal structure of 1-ethyl-2-nitro-imidazole oxide, C5H7N3O3
  47. The crystal structure of 2-(2-fluorophenyl)naphtho[2,1-d]thiazole, C17H10FNS
  48. Crystal structure of (E)-2,4-di-tert-butyl-6-(((2-fluorophenyl)imino) methyl)phenol, C21H26FNO
  49. Synthesis and crystal structure of 3-methyl-2-(methylthio)-4H-chromen-4-one, C12H12O2S
  50. Crystal structure of dithieno[2,3-d:2′,3′-d′]benzo[1,2-b:4,5-b′]dithiophene-5,10-dione, C14H4O2S4
  51. The crystal structure of dimethyl 2,2ʹ-((adamantane-1,3-diylbis(4,1-phenylene)) bis(oxy))diacetate, C28H32O6
  52. The crystal structure of N-(6-chloro-2-methyl-2H-indazol-5-yl)acetamide, C10H10ClN3O
  53. Crystal structure of triaqua-(5-bromoisophthalato-κ1 O)-(2,2′-bipyridine-κ2 N:N′)nickel(II) hydrate, C18H19BrN2NiO8
  54. The crystal structure of 2-amino-4-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
  55. The crystal structure of catena-poly[5-aminonicotinic acid-k1 N-m2-bromido-copper(I)], Cu(C6N2H6O2)Br
  56. The crystal structure of 2,2-bis(3-methoxyphenyl)-1-tosyl-1,2-dihydro- 2λ4,3λ4  -[1,3,2]diazaborolo[4,5,1-ij]quinoline - dichloromethane (1/1)
  57. The crystal structure of catena-poly[bis(6-phenylpyridine-2-carboxylato-κ2 N,O)-(μ2-4,4′-bipyridne-κ2 N:N)cadmium(II)], C34H24N4O4Cd
  58. The crystal structure of 5,7-dinitropyrazolo[5,1-b]quinazolin-9(4H)-one, C10H5N5O5
  59. Crystal structure of rac-1,8-bis(2-carbamoylethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H46N6O2
  60. The crystal structure of (E)-N ′-(2-bromobenzylidene)-2-naphthohydrazide, C36H26Br2N4O2
  61. The crystal structure of 5-nitronaphthoquinone, C10H5NO4
  62. The crystal structure of (S, R p )-4–benzhydrylideneamino-12-(4-tert-butyl oxazolin-2-yl)[2.2]paracyclophane, C36H36N2O
  63. Synthesis and crystal structure of 2-(2-oxo-2-(o-tolyl)ethyl)-4H-chromen-4-one, C18H14O3
  64. Crystal structure of 2-(thiazol-2-yl)hexahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione, C11H10N2O3S
  65. Crystal structure of N-(diaminomethylene)-1-(dimethylamino)-1-iminiomethanaminium dichloride, C4H13Cl2N5
  66. Crystal structure of poly[(μ3-3, 5-dichloro-2-hydroxy-benzoato-κ4 Cl,O:O′:O″) silver(I)], C7H3AgCl2O3
  67. The crystal structure of tetrakis(1-isopropylimidazole-κ1 N)-[μ2- imidazole-4,5-dicarboxylato-κ4 O,N,O′,N′)]- trioxido-divanadium, C29H41N10O7V2
  68. Crystal structure of catena-[(μ3-bromido)-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N)copper(I)], C9H7BrCuN3O2
  69. The crystal structure of (E)-4-fluoro-N′-(1-(2-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
https://doi.org/10.1515/ncrs-2023-0126
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of a polymorph of potassium picrate, C6H2KN3O7
  4. The crystal structure of (1E,2E)-1,2-bis(quinolin-2-ylmethylene)hydrazine, C20H14N4
  5. 5-Amino-2-chloro-4-fluoro-N-(N-isopropyl-N-methylsulfamoyl) benzamide, C11H15O3ClFN3S
  6. Crystal structure of trans-N 1,N 8-bis(2-cyanoethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H42N6
  7. The crystal structure of [N-{[2-(oxy)-4-methoxyphenyl](phenyl)methylidene}alaninato]-diphenyl-silicon(IV) – chloroform (1/1), C29H25NO4Si·CHCl3
  8. Crystal structure of tetracarbonyl-{μ-[N-(diphenylphosphanyl)-N,P,P-triphenylphosphinous amide]}-bis[μ-(phenylmethanethiolato)]diiron (Fe–Fe), C48H39Fe2NO4P2S2
  9. Crystal structure of baryte from Mine du Pradet (France)
  10. The crystal structure of [(2,2′-bipyridine-6-carboxylato-κ3 N,N,O)-(6-phenylpyridine-2-carboxylate-κ2 N,O)copper(II)] monohydrate, C23H17N3O5Cu
  11. Crystal structure of bis(μ-benzeneselenolato)-(μ-[N-benzyl-N-(diphenylphosphanyl)-P,P-diphenylphosphinous amide])-tetracarbonyl diiron (Fe–Fe), C47H37Fe2NO4P2Se2
  12. The crystal structure of diaqua-methanol-κ1 O- (3-thiophenecarboxylato-κO)-(2,2′-dipyridyl-κ2 N,N′)manganese(II) 3-thiophenecarboxylate, C21H22N2O7S2Mn
  13. Crystal structure of catena-poly[tetrakis(butyl)-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O:O,O′,N-μ2-2-((oxido(phenyl)methylene)hydrazineylidene)propanoato-κ4 O,N,O′:N′-ditin(IV)], C34H50N6O6Sn2
  14. Crystal structure of 4-chloro-N′-[(1E)-(2-nitrophenyl)methylidene]benzohydrazide, C14H10ClN3O3
  15. The crystal structure of 3-(1′-deoxy-3′,5′-O-dibenzy-β-d-ribosyl)adenine dichloromethane solvate, C49H52Cl2N10O6
  16. The crystal structure of (Z)-4-amino-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H17N3O
  17. The co-crystal structure of etoricoxib–phthalic acid (1/1), C18H15ClN2O2S·C8H6O4
  18. Crystal structure of (glycinto-κ 2 O,N ′)-[5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane-κ 4 N,N ′,N ″,N ‴]nickel(II) perchlorate monohydrate C18H42ClN5NiO7
  19. The crystal structure of catena-poly[bis(1-ethylimidazole-k1 N)-(μ 2-benzene-1-carboxyl-3,5-dicarboxylato-κ 2 O, O′)zinc(II)], C19H20N4O6Zn
  20. Crystal structure of 3-(thiazol-2-ylcarbamoyl)-7-oxabicyclo[2.2.1]heptane-2-carboxylic acid, C11H12N2O4S
  21. Rietveld structure analysis of keatite, a rare, metastable SiO2 polymorph
  22. Crystal structure of catena-poly[(μ2-isophthalato-k3 O,O′:O″)(4-(4-pyridyl)-2,5-dipyrazylpyridine-k3 N,N′,N″)cobalt(II)] trihydrate C26H22N6O7Co1
  23. Crystal structure of 3,5–di-O-benzoyl-1,2-O-isopropylidene-α–D-ribose, C22H22O7
  24. The crystal structure of fac-tricarbonyl(6-bromo-2,2-bipyridine-κ2 N,N)-(nitrato-κO)rhenium(I), C13H7BrN3O6Re
  25. The crystal structure of (E)-N′-(4-hydroxy-3-methoxybenzylidene)-2-naphthohydrazide monohydrate, C19H18N2O4
  26. The crystal structure of 5,5′-diselanediyl-bis(2-hydroxybenzaldehyde), C14H10O4Se2
  27. The crystal structure of catena-poly[diaqua-m2-dicyanido-κ2 C:N-dicyanido-κ1 C-bis(4-(pyridin-4-yl)benzaldehyde-κ1N)iron(II)-platinum(II), C28H22N6O4PtFe
  28. Redetermination of the crystal structure of 5,14-dihydro-6,17-dimethyl-8,15-diphenyldibenzo(b,i)(1,4,8,11)tetra-azacyclotetradecine, C32H28N4
  29. Crystal structure of poly[(μ3-2-(3,5-dicarboxyphenyl) benzimidazole-6-carboxylato-κ4O:O:O′:O″)lead(II)] monohydrate, C16H10N2O7Pb
  30. The crystal structure of fac-tricarbonyl(2-pyridin-2-yl-quinoline-κ2 N,N′)-(pyrazole-κN)rhenium(I)nitrate, C20H14N4O3ReNO3
  31. Crystal structure of dibromo-dicarbonyl-bis(tricyclohexylphosphine)-osmium(II) dichloromethane solvate, C38H66Br2O2OsP2
  32. Crystal structure of poly[bis(μ 2-2,6-bis(1-imidazoly)pyridine-κ 2 N:N′)copper(II)] diperchlorate dihydrate, C22H22Cl2CuN10O10
  33. The crystal structure of fac-tricarbonyl(N-benzoyl-N,N-cyclohexylmethylcarbamimidothioato-κ2 S,O)-(pyridine-κN)rhenium(I), C23H24N3O4ReS
  34. Crystal structure of (E)-7-fluoro-2-(4-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O
  35. Synthesis and crystal structure of 1-((3R,10S,13S, 17S)-3-((2-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO2
  36. The crystal structure of fac-tricarbonyl((pyridin-2-yl)methanamino-κ2 N,N′)-((pyridin-2-yl)methanamino-κN)rhenium(I) nitrate, C15H16O3N4Re
  37. The crystal structure of (1-(pyridin-2-yl)-N-(pyridin-2-ylmethyl)-N-((1-(4-vinylbenzyl)-1H-benzo[d]imidazol-2-yl)methyl)methanamine-κ 4 N,N′,N″,N‴)tris(nitrato-kO,O′)-erbium(III), C29H27ErN8O9
  38. Crystal structure of tetracene-5,12-dione, C18H10O2
  39. Crystal structure of (3R,3aS,6R,6aR)-6-hexyl-3-methyltetrahydrofuro[3,4-b]furan-2,4-dione, C13H20O4
  40. The crystal structure of N′1,N′3-bis((E)-thiophen-2-ylmethylene)isophthalohydrazide monohydrate, C18H16N4O3S2
  41. Crystal structure of methyl ((4-aminobenzyl)sulfonyl)-L-prolinate, C13H18N2O4S
  42. Crystal structure of (E)-3-(3-methoxybenzylidene)benzofuran-2(3H)-one, C16H12O3
  43. Synthesis and crystal structure (E)-1-(4-bromo-2-hydroxyphenyl)-3-(dimethylamino)prop-2-en-1-one, C11H12BrNO2
  44. Synthesis and crystal structure of (S,E)-4-hydroxy-3-(2-((4aR,6aS,7R,10aS,10bR)-3,3,6a,10b-tetramethyl-8-methylenedecahydro-1H-naphtho[2,1-d][1,3]dioxin-7-yl)ethylidene)dihydrofuran-2(3H)-one, C23H34O5
  45. The crystal structure of N,N′-(1,2-phenylene)bis (2-((2-oxopropyl)selanyl)benzamide), C26H24N2O4Se2
  46. The crystal structure of 1-ethyl-2-nitro-imidazole oxide, C5H7N3O3
  47. The crystal structure of 2-(2-fluorophenyl)naphtho[2,1-d]thiazole, C17H10FNS
  48. Crystal structure of (E)-2,4-di-tert-butyl-6-(((2-fluorophenyl)imino) methyl)phenol, C21H26FNO
  49. Synthesis and crystal structure of 3-methyl-2-(methylthio)-4H-chromen-4-one, C12H12O2S
  50. Crystal structure of dithieno[2,3-d:2′,3′-d′]benzo[1,2-b:4,5-b′]dithiophene-5,10-dione, C14H4O2S4
  51. The crystal structure of dimethyl 2,2ʹ-((adamantane-1,3-diylbis(4,1-phenylene)) bis(oxy))diacetate, C28H32O6
  52. The crystal structure of N-(6-chloro-2-methyl-2H-indazol-5-yl)acetamide, C10H10ClN3O
  53. Crystal structure of triaqua-(5-bromoisophthalato-κ1 O)-(2,2′-bipyridine-κ2 N:N′)nickel(II) hydrate, C18H19BrN2NiO8
  54. The crystal structure of 2-amino-4-carboxypyridin-1-ium perchlorate, C6H7ClN2O6
  55. The crystal structure of catena-poly[5-aminonicotinic acid-k1 N-m2-bromido-copper(I)], Cu(C6N2H6O2)Br
  56. The crystal structure of 2,2-bis(3-methoxyphenyl)-1-tosyl-1,2-dihydro- 2λ4,3λ4  -[1,3,2]diazaborolo[4,5,1-ij]quinoline - dichloromethane (1/1)
  57. The crystal structure of catena-poly[bis(6-phenylpyridine-2-carboxylato-κ2 N,O)-(μ2-4,4′-bipyridne-κ2 N:N)cadmium(II)], C34H24N4O4Cd
  58. The crystal structure of 5,7-dinitropyrazolo[5,1-b]quinazolin-9(4H)-one, C10H5N5O5
  59. Crystal structure of rac-1,8-bis(2-carbamoylethyl)-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane, C22H46N6O2
  60. The crystal structure of (E)-N ′-(2-bromobenzylidene)-2-naphthohydrazide, C36H26Br2N4O2
  61. The crystal structure of 5-nitronaphthoquinone, C10H5NO4
  62. The crystal structure of (S, R p )-4–benzhydrylideneamino-12-(4-tert-butyl oxazolin-2-yl)[2.2]paracyclophane, C36H36N2O
  63. Synthesis and crystal structure of 2-(2-oxo-2-(o-tolyl)ethyl)-4H-chromen-4-one, C18H14O3
  64. Crystal structure of 2-(thiazol-2-yl)hexahydro-1H-4,7-epoxyisoindole-1,3(2H)-dione, C11H10N2O3S
  65. Crystal structure of N-(diaminomethylene)-1-(dimethylamino)-1-iminiomethanaminium dichloride, C4H13Cl2N5
  66. Crystal structure of poly[(μ3-3, 5-dichloro-2-hydroxy-benzoato-κ4 Cl,O:O′:O″) silver(I)], C7H3AgCl2O3
  67. The crystal structure of tetrakis(1-isopropylimidazole-κ1 N)-[μ2- imidazole-4,5-dicarboxylato-κ4 O,N,O′,N′)]- trioxido-divanadium, C29H41N10O7V2
  68. Crystal structure of catena-[(μ3-bromido)-(1H-1,2,4-triazol-1-yl)benzoato-κ1 N)copper(I)], C9H7BrCuN3O2
  69. The crystal structure of (E)-4-fluoro-N′-(1-(2-hydroxyphenyl)propylidene)benzohydrazide, C16H15FN2O2
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0126/html
Button zum nach oben scrollen